Key Developments: Accuray Incorporated (ARAY.O)

ARAY.O on Consolidated Issue listed on NASDAQ Global Market

7.22USD
9 Feb 2010
Price Change (% chg)

$0.10 (+1.40%)
Prev Close
$7.22
Open
--
Day's High
$7.25
Day's Low
$6.86
Volume
803,058
Avg. Vol
508,579
52-wk High
$8.35
52-wk Low
$3.78

Research a stock:

Latest Key Developments

Accuray Incorporated Raises Low End Of Prior FY 2010 Revenue Guidance To A Range Above Analysts' Estimates
Thursday, 4 Feb 2010 04:10pm EST 

Accuray Incorporated announced that for fiscal 2010, it expects revenue to be in the range of $220-$230 million, up from its prior guidance of $215-$230 million. According to Reuters Estimates, analysts were expecting the Company to report revenues of $219 million for the same period. 

Accuray Incorporated Announces First CyberKnife In Belgium To Be Installed At University Hospital
Monday, 14 Dec 2009 08:30am EST 

Accuray Incorporated announced that the first CyberKnife Robotic Radiosurgery System in Belgium will be installed at the University Hospital of Liege. Accuray develops and markets the CyberKnife Robotic Radiosurgery System. 

Accuray Incorporated Introduces the CyberKnife VSI System
Saturday, 31 Oct 2009 10:00pm EDT 

Accuray Incorporated announced the introduction of the CyberKnife VSI System, the latest addition to the CyberKnife product family. The new CyberKnife VSI, which stands for versatile, simple and intelligent, is designed to broaden physicians' range of options from radiosurgery to also include conventionally fractionated Robotic IMRT. 

Accuray Incorporated Reiterates FY 2010 Revenue Outlook
Thursday, 29 Oct 2009 04:10pm EDT 

Accuray Incorporated reiterated its fiscal 2010 outlook and expects revenue in the range of $215-$230 million. According to Reuters Estimates, analysts were expecting the Company to report revenues of $218 million for the same period. 

Accuray Incorporated Announces Installation Of First CyberKnife System In Canada
Wednesday, 16 Sep 2009 10:47am EDT 

Accuray Incorporated announced that Centre Hospitalier de l'Universite de Montreal (CHUM) has installed a CyberKnife Robotic Radiosurgery System at Hopital Notre-Dame du CHUM, in Montreal, Canada. 

Accuray Incorporated Issues Q1, FY 2010 Revenue Guidance Below Analysts' Estimates
Monday, 24 Aug 2009 04:23pm EDT 

Accuray Incorporated announced that for fiscal 2009, it expects revenue to be in the range of $215 to $230 million. For first quarter of 2010, it expects revenue to be in the range of $40 to $50 million. According to Reuters Estimates, analysts were expecting the Company to report revenue of $59 million for first quarter of 2010; revenue of $232 million for fiscal 2010. 

Shalov Stone Bonner & Rocco LLP Files Class Action Against Accuray Incorporated
Wednesday, 19 Aug 2009 08:29pm EDT 

Shalov Stone Bonner & Rocco LLP announced that it has filed a class action lawsuit on behalf of purchasers of the common stock of Accuray Incorporated between February 7, 2007, and August 19, 2008, inclusive (the Class Period). Also included are purchasers of Accuray common stock pursuant or traceable to the Company's Initial Public Offering on or about February 7, 2007. The lawsuit is pending in the United States District Court for the Northern District of California. The complaint alleges that, throughout the Class Period, the defendants made false and misleading statements concerning Accuray's financial performance, but failed to disclose that: Accuray amended its definition of backlog to include both contingent and non-contingent contracts; that a considerable percentage of contingent and non-contingent orders for the CyberKnife system that did not have a high probability of being booked as revenue were reported as backlog; Accuray's backlog was overstated by at least $127 million; Accuray sales personnel entered into contingent contracts for CyberKnife systems that did not have a high probability of being booked as revenue; the Company lacked adequate internal controls and procedures to ensure that potential orders reported as backlog had a substantially high probability of being booked as revenue; and that based on the foregoing, defendants did not have a reasonable basis for their positive statements about Accuray, its backlog, earnings, operations and prospects. 

Accuray Incorporated Announces CyberKnife System In South Korea Purchased
Wednesday, 12 Aug 2009 08:30am EDT 

Accuray Incorporated announced that the Gyeongsang National University Hospital (GNUH) in Jinju, South Korea has purchased a CyberKnife Robotic Radiosurgery System. This marks the seventh System sold in the country and its first equipped with the RoboCouch Patient Positioning System. GNUH is the first national university hospital in the country to purchase the System, allowing patients greater access to the benefits of radiosurgery. 

lancy Binkow & Goldberg LLP Files Class Action Lawsuit Against Accuray Incorporated
Friday, 7 Aug 2009 08:51pm EDT 

Accuray Incorporated announced that notice is given that Glancy Binkow & Goldberg LLP has filed a class action lawsuit in the United States District Court for the Northern District of California on behalf of a class consisting of all persons or entities who purchased the common stock of the Company pursuant and/or traceable to the Company's Initial Public Offering commencing on or about February 7, 2007, including purchasers of the Company's common stock between February 7, 2007 and August 19, 2008, inclusive (the Class Period). 

Shalov Stone Bonner & Rocco LLP Announces Class Action Against Accuray Incorporated
Wednesday, 5 Aug 2009 01:25pm EDT 

Shalov Stone Bonner & Rocco LLP announced that a class action lawsuit has been filed on behalf of purchasers of the common stock of Accuray Incorporated between February 7, 2007 and August 19, 2008, inclusive (the Class Period). Also included are purchasers of Accuray common stock pursuant or traceable to the Company's Initial Public Offering on or about February 7, 2007. The lawsuit is pending in the United States District Court for the Northern District of California. The complaint alleges that, throughout the Class Period, the defendants made false and misleading statements concerning Accuray's financial performance, but failed to disclose that: Accuray amended its definition of backlog to include both contingent and non-contingent contracts; that a considerable percentage of contingent and non-contingent orders for the CyberKnife system that did not have a high probability of being booked as revenue were reported as backlog; Accuray's backlog was overstated by at least $127 million; Accuray sales personnel entered into contingent contracts for CyberKnife systems that did not have a high probability of being booked as revenue; the Company lacked adequate internal controls and procedures to ensure that potential orders reported as backlog had a substantially high probability of being booked as revenue; and that based on the foregoing, defendants did not have a reasonable basis for their positive statements about Accuray, its backlog, earnings, operations and prospects. 

HEADLINE STOCKS-Some U.S. stocks on the move on Aug. 25

(Updates to afternoon trading, adds Willdan, Fairfax, Daktronics, Human Genome, Freddie Mac/Fannie Mae)

Research a stock: